Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.534, 2007-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Reducing the burden of congenital syphilis: which options best?
Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. :
Access to resources
Recommend
Preventing CMV infection - which strategy's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
Measuring indirect costs: which method's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. :
TB drug susceptibility testing strategies: which is best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. :
Which cervical cancer screening interval and test is best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 646, 2012-01 ,pp. :